The abstract is read at the publisher; the summary is JClub's.
Single-cell RNA sequencing and spatial multiomics have advanced melanoma research by resolving intra-tumoural heterogeneity and tumour microenvironment interactions linked to therapy resistance.
- Why it matters: Bulk sequencing cannot capture cellular nuances that drive resistance, so the field needs higher-resolution maps of malignant states and immune ecosystems to guide therapy.
- What they did: The review synthesizes recent single-cell multiomics studies, emphasizing drug-tolerant persister states, immune escape mechanisms, and resistance-associated cellular transitions, and discusses computational modeling plus pharmacological validation.
- The result: Integrating multiomics profiling with modeling and validation is presented as a framework for target discovery, biomarker development, and rational combination therapy design in refractory melanoma.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.